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Data Sources
The Community Epidemiology Work Group
(CEWG) is sponsored by the National Institute on
Drug Abuse (NIDA). It is a group of 21 researchers
from across the nation who meet twice a year to report
on drug abuse patterns and trends and emerging prob-
lems in their local areas. Members use quantitative
statistics and qualitative techniques such as focus
groups and key informant interviews to monitor drug
trends. The information in this paper is taken from the
author’s notes from the June and December, 2003
CEWG meetings.The full reports of the CEWG can be
accessed at www.nida.nih.gov/about/organization/
cewg/Reports.html.
The Monitoring the Future Survey (MTF) is con-
ducted by the University of Michigan’s Institute for
Social Research and is funded by NIDA. It tracks illicit
drug use and attitudes towards drugs by eighth, tenth,
and twelfth graders as well as college students and
young adults. The results of the 2003 survey of second-
ary school students are included, but the results of
the 2003 survey of college students and young adults
had not been released at the time this paper was
published. The MTF reports can be accessed at
www.monitoringthefuture.org.
The National Survey on Drug Use and Health
(NSDUH), formerly called the National Household
Club drugs such as MDMA, MDA, GHB, ketamine, LSD, methamphet-
amine, and Rohypnol were initially characterized as substances used at raves
and dance parties. Often there was little recognition that each of these drugs
has very different pharmacological, psychological, and physiological proper-
ties. As more data have become available, it has become clearer that there are
important differences in the characteristics of people who use each of these
drugs and the patterns of their use. Prevention and treatment efforts need to
take these differences into account. For information on the properties of these
drugs, including summaries of the research on their adverse effects and their
toxicological properties, see J. C. Maxwell, Response to Club Drug Use.
Current Opinion in Psychiatry May 2003, 16, 279–289.
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Survey on Drug Abuse (NHSDA), is conducted by the
Office of Applied Studies of the Substance Abuse and
Mental Health Services Administration (SAMHSA). It
collects information on the prevalence, patterns, and
consequences of alcohol, tobacco, and illegal drug use
and abuse in the general U.S. civilian non-institutional-
ized population, ages 12 and older. The survey reports
can be found at www.samhsa.gov/oas/nhsda.htm.
The Drug Abuse Warning Network (DAWN)
collects data on drug-related visits to a sample of the
Nation’s emergency departments (EDs). Visits can
include drug abuse and misuse, adverse reactions,
accidental ingestion, overmedication, malicious poison-
ing, suicide attempts, underage drinking, and patients
seeking detoxification or drug abuse treatment.
DAWN is conducted by the Office of Applied Studies
of the SAMHSA. The reports are available at
http://dawninfo.samhsa.gov.
The National Forensic Laboratory Information
System (NFLIS), sponsored by the Drug Enforce-
ment Administration (DEA), is a program that
systematically collects results from toxicological
analyses conducted by state and local forensic labora-
tories on substances seized in law enforcement
operations. The NFLIS reports are online at
www.deadiversion.usdoj.gov/nflis.
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ECSTASY (MDMA)
MDMA (3-4 methylenedioxy-methamphetamine) (also
called Adam, E, X, eccie) is a synthetic, psychoactive
drug with both stimulant and hallucinogenic properties
similar to methamphetamine and mescaline. It has been
a Schedule I drug since 1985. A similar compound, 3, 4-
methylenedioxyamphetamine (MDA), is also classified
as a Schedule I drug.
The effects and pharmacological actions of 3, 4-
methylenedioxyethamphetamine (MDEA, Eve) are
reported to be similar, but not identical to MDMA.
Other drugs which appear in the ecstasy scene include
p-methoxyamphetamine (paramethoxyamphetamine)
(PMA), a drug packaged as ecstasy and which is mistak-
enly assumed to be a by-product in the synthesis of
MDMA. PMA shares the stimulant and hallucinogenic
effects of MDMA as well as its risk of hyperthermia,
and fatalities related to the use of PMA have been
reported. Another new derivative of amphetamine, 4-
MTA (p-methylthioamphetamine), has been associated
with deaths since it was first identified in Europe in
1997. Sold as “ecstasy” or “Flatliners,” the drug is a
potent serotonin releaser.
Many surveys and studies such as MTF, NSDUH, and
DAWN query about use of “MDMA” when the term
“ecstasy” would be more appropriate, since users hope
they are consuming MDMA but do not actually know
what is in the pill unless a toxicological test has been
run. In this paper, the term “ecstasy” will be used
except in discussing the NFLIS data, which reflect the
results of the chemical analysis.
MDA was reported as early as the June, 1980 meeting
of the CEWG and MDMA was first reported at the
December, 1985 meeting. At the June and December,
2003 CEWG meetings, it was reported that in Atlanta,
ecstasy use was no longer seen as a club drug, but is
now being used by low income polydrug users and use
has also spread to the African American community.
Methamphetamine and ecstasy were being used in
combination because the effects of ecstasy alone were
“not enough,” and ecstasy was being bought in larger
quantities, with some users reported to be developing
tolerance to the drug. “Trolling,” which is using ecstasy
and LSD together, was also reported. In Baltimore,
ecstasy was more prevalent in the central city and the
increase was said to be due to the Hip-Hop culture and
rap songs about ecstasy. In Chicago, ecstasy use was
reported as down and the price was stable; however, it
was spreading to new groups of Anglo suburban youth.
In Detroit, ecstasy use was stable, particularly outside
Detroit, where it is known as a “Prom” drug. In Miami,
ecstasy use was reported as “passé” but that when it
was used, it was used in combination with other drugs,
including Viagra, primarily in the gay “Party and Play”
club scene. This same Party and Play phenomenon
was reported in San Francisco, where ecstasy use was
reported down.
In Minneapolis-St. Paul, ecstasy use was reported as
level, and it was used in combination with ketamine and
methamphetamine. Ecstasy and ketamine are often sold
together in Philadelphia. In St. Louis, ecstasy was
available in clubs and around colleges and there were
reports of gay males using Viagra and ecstasy (“Party
Packs”). In New York City, ecstasy use was reported up,
especially among Hispanics and African Americans. Use
was reported as stable in Boston. In San Diego, use of
ecstasy was reported as declining, and Mexican meth-
amphetamine was being pressed into pills that look like
ecstasy. In Seattle, use was higher among young males
having sex with males, and there were reports of
depression among users. In Los Angeles, ecstasy use
was reported as down. In Texas, the number of treat-
ment admissions with a problem with ecstasy had
increased from 63 in 1998 to 521 in 2002, and the
proportion of Anglo clients was decreasing, while
African American and Hispanic admissions were
increasing—a further indication that ecstasy has
spread beyond the Anglo club culture.
After a period of rapid increase in use, the
national surveys, DAWN, and NFLIS all docu-
ment that ecstasy use is now decreasing. At
the same time, use is spreading from “raves”
and dance parties into other venues and
neighborhoods. Ecstasy users are among
the youngest club drug users, and the
proportions who are Anglo or are male have
decreased. Users of ecstasy also tend to
use alcohol, marijuana, and cocaine, and
they often seek help in hospital emergency
departments for unexpected reactions
or overdose.Patterns of Club Drug Use in the U.S., 2004
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Ecstasy is not a major drug of
abuse, based on law enforcement
seizures. NFLIS reported that in the
first half of 2003, 0.66% of all
items identified were MDMA, as
compared to 37% that were can-
nabis/THC and 32% that were
cocaine (Exhibit 1). The proportion
of items that were MDMA has
dropped from a high of 1.17% of
all items in 2001 (Exhibit 2). Of the
4,296 “club drug” items that were
identified in 2003, 3,310 (77%) were
MDMA, 374 (9%) were MDA, 16
(0.4%) were MDEA, and 1 (0.02%)
was PMA.
The MTF survey reported that lifetime, past year, and
past month use of ecstasy peaked for eighth, tenth, and
twelfth graders in 2001 and has declined since. For all
three grades, the declines between 2002 and 2003 in
both annual prevalence and 30-day prevalence were
statistically significant (Exhibit 3). The decline in
prevalence of use appears related to perceptions of
risk and availability (Exhibit 4). In 2000, only 38%
of twelfth graders said there was a great risk of harm
associated with trying ecstasy; that increased to 56%
in 2003. And the perceived availability of ecstasy as
reported by the students decreased from a high of
62% in 2001 to 58% in 2003, while the disapproval
of people who tried ecstasy once or twice increased
from 81% in 2001 to 85% in 2003.
The MTF survey also reported that for college students,
lifetime, past year, and past month use peaked in 2001
and declined in 2002. For young adults ages 19–40,
lifetime use increased in 2002, but past year and past
month use decreased; none of the changes for college
students or young adults were significant.
The NSDUH survey in 2002 reported that 4.3% of the
U.S. population ages 12 and over had ever used ecstasy,
1.3% had used in the past year, and 0.3% had used in
the past month. Some 2.2% of those ages 12–17 had
used ecstasy in the past year, as compared to 5.8% of
those 18–25 and 0.5% of those 26 and older. Initiation
of ecstasy use began rising in 1993, when there were
168,000 new users. There were 1.9 million new users in
2000, but the number decreased to 1.8 million new
users in 2001 (Exhibit 5).
The number of mentions of ecstasy in emergency
rooms monitored by DAWN increased from 253 in
1994 to 5,542 in 2001 and then dropped back to 4,026
in 2002, a non-significant change. Exhibit 6 shows the
rates of ecstasy mentions per 100,000 population.
Emergency department patients mentioning use of
ecstasy were younger than users of all other club drugs
except LSD (Exhibit 7). Fifty percent of the patients
mentioning ecstasy in 2002 were male, as compared to
62% in 1999. The race/ethnic distribution has changed.
In 1999, 74% were Anglo, as compared to 64% in 2002.
In 2002, 12% were African American and 9% were
Hispanic; race/ethnicity was not reported for 15%
of patients.
Exhibit 8 shows that 72% used ecstasy in combination
with other drugs, which included alcohol (40%), mari-
juana (39%), or cocaine (20%). The motive for using
ecstasy was psychic effects (56%) or dependence (21%)
(Exhibit 9), and the reasons given for seeking emer-
gency room services were unexpected reaction (39%)
or overdose (30%) (Exhibit 10).
GHB, GBL, and 1,4-BD
Gamma hydroxybutyrate (sodium hydroxybutyrate,
sodium oxybutyrate, GHB), a naturally occurring fatty
acid found in mammals, is a central nervous system
depressant which has intoxicating effects, and at suffi-
ciently high doses, anesthetic properties. In 1990, after
reports of adverse events, the Food and Drug Adminis-
tration (FDA) ordered the removal of GHB from the
market. GHB produces anterograde amnesia and may
cause victims to lose consciousness and be unable to
resist or recall sexual assault. Because of its use to
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Exhibit 1. Substances Identified by Laboratories Participating in the National 
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commit assault and its use as a club drug, it is now a
Schedule I drug.
GHB is known on the street by terms such as Fantasy,
liquid ecstasy, liquid X, Grievous Bodily Harm, scoop,
cherry meth, soap, salty water, organic quaalude, G,
Growth Hormone Booster, Somatomax PM, Gamma
OH, and Georgia Home Boy. It is available as a powder
or a liquid.
One of its precursors, gamma butyrolactone (GBL), is
converted to GHB when ingested. GBL is used as an
industrial solvent and has been marketed as a dietary
supplement and cleaner for computer parts such as ink
jet printers or VCRs. Various brand names include
Fire Water, Revivarant, Revivarant G, RenewTrient,
GH Revitalizer, Verve, GH Release, Gamma-G,
InvigorateX-Depress, Furomax, Insom-X, and Blue
Nitro. GBL is a List I chemical in the U.S. and requires
documentation and justification of all purchases and
sales. If intended for human consumption, GBL
and related substances are regarded as controlled-
substance analogues.
Another precursor is 1,4 butanediol (1,4-BD), which is
a Class I health hazard and is an industrial solvent sold
to abusers under names such as (Revital)ize Plus,
Serenity, Enliven, GHRE, Somato-Pro, NRG3, Weight
Belt Cleaner, Thunder Nectar, Pine
Needle Extract, and Pine Needle Oil.
It is metabolized in the body to GBL,
which is then metabolized to GHB.
Illegal GHB and its precursors, GBL
and 1,4-BD, can be obtained over the
Internet and sometimes are marketed
as solvents or as dietary supplements
in health food stores, gyms, raves,
and nightclubs. Chemistry kits, reagents, and recipes are
available on the web to convert the precursors into
GHB, and GHB itself can be ordered from websites in
some other countries.
GHB was first reported at a CEWG meeting in Decem-
ber, 1990. At the June and December, 2003 CEWG
meetings, reports of use of GHB varied across the
nation. In Atlanta, it was prevalent in the gay scene. In
Chicago, levels of use of GHB were low and it tended
to be used by young heroin inhalers. In Miami, Minne-
apolis-St. Paul, Detroit, and San Francisco, use was
reported as down. In Los Angeles, typical users were
older Anglo males. Use in Texas was centered in the
Dallas-Fort Worth metroplex area.
NFLIS reported that in 2002, there were 549 items
identified as being GHB or GBL (4% of all club drugs
identified). The number of GHB exhibits has been
dropping since 2000 (Exhibit 2).
The MTF survey showed that between 2000 and 2003,
use for eighth and twelfth graders decreased while use
by tenth graders remained level. Past year use in 2002
by college students and by young adults was as low or
lower than for secondary school students (Exhibit 3).
The NSDUH did not survey for use of GHB.
DAWN emergency room mentions of GHB, GBL or
1,4-BD increased from 56 in 1994 to a high of 4,969 in
2000, and then declined to 3,330 in 2002. Exhibit 6
shows this change based on the number of mentions
per 100,000 population. Patients mentioning GHB
were older than all other club drug users except meth-
amphetamine patients (Exhibit 7). Some 66% were
male, 92% were Anglo, and 1% were Black; race/
ethnicity was not reported for 7% (Exhibit 8). This
same demographic pattern was seen in 1999.
GHB use is decreasing, based on data from
forensic labs and hospital emergency rooms.
GHB users are older, Anglo, and male. They
are the most likely of all club drug users to
use other drugs at the same time, especially
alcohol. GHB was taken for its psychic ef-
fects, and the primary reason for entering
the hospital emergency department was
an overdose.
Exhibit 2. Percent of Club Drug Items Identified by NFLIS Labs: 1997-First Half 2003
1997 1998 1999 2000 2001 2002 2003
MDMA 0.13% 0.36% 0.73% 1.17% 1.02% 0.66%
GHB 0.00% 0.03% 0.06% 0.09% 0.04% 0.06% 0.04%
Ketamine 0.00% 0.01% 0.06% 0.11% 0.15% 0.16% 0.07%
LSD 0.27% 0.56% 0.43% 0.22% 0.14% 0.02% 0.03%
Methamphetamine 3.58% 2.03% 7.60% 9.84% 10.50% 11.79% 11.82%
Rohypnol 0.03% 0.05% 0.02% 0.01% 0.01% 0.01% 0.00%
0.03%Patterns of Club Drug Use in the U.S., 2004
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Exhibit 3. Past-Year Prevalence of Club Drugs from the Monitoring the Future Surveys: 1991-2003
Past Year Use of MDMA (Ecstasy)
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 2.3 2.3 1.8 1.7 3.1 3.5 2.9 2.1 *
10th grade 4.6 3.9 3.3 4.4 5.4 6.2 4.9 3.0 ***
12th grade 4.6 4.0 3.6 5.6 8.2 9.2 7.4 4.5 ***
College students 0.9 2.0 0.8 0.5 2.4 2.8 2.4 3.9 5.5 9.1 9.2 6.8 …
Young adults 0.8 1.0 0.8 0.7 1.6 1.7 2.1 2.9 3.6 7.2 7.5 6.2 …
Past Year Use of GHB
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 1.2 1.1 0.8 0.9
10th grade 1.1 1.0 1.4 1.4
12th grade 1.9 1.6 1.5 1.4
College students 0.6 …
Young adults 0.8 …
Past Year Use of Ketamine
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 1.6 1.3 1.3 1.1
10th grade 2.1 2.1 2.2 1.9
12th grade 2.5 2.5 2.6 2.1
College students 1.3 …
Young adults 1.2 …
Past Year Use of LSD
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 1.7 2.1 2.3 2.4 3.2 3.5 3.2 2.8 2.4 2.4 2.2 1.5 1.3
10th grade 3.7 4.0 4.2 5.2 6.5 6.9 6.7 5.9 6.0 5.1 4.1 2.6 1.7 **
12th grade 5.2 5.6 6.8 6.9 8.4 8.8 8.4 7.6 8.1 6.6 6.6 3.5 1.9 ***
College students 5.1 5.7 5.1 5.2 6.9 5.2 5.0 4.4 5.4 4.3 4.0 2.1 … **
Young adults 3.8 4.3 3.8 4.0 4.6 4.5 4.4 3.5 4.0 3.7 3.4 1.8 … ***
Past Year Use of Methamphetamine
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 3.2 2.5 2.8 2.2 2.5
10th grade 4.6 4.0 3.7 3.9 3.3
12th grade 4.7 4.3 3.9 3.6 3.2
College students 3.3 1.6 2.4 1.2 …
Young adults 2.8 2.5 2.8 2.5 …
Past Year Use of Ice
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
12th grade 1.4 1.3 1.7 1.8 2.4 2.8 2.3 3.0 1.9 2.2 2.5 3.0 2.0 **
College students 0.1 0.2 0.7 0.8 1.1 0.3 0.8 1.0 0.5 0.5 0.6 0.8 …
Young adults 0.3 0.4 0.8 0.9 1.2 0.9 0.9 1.1 0.9 1.2 1.1 1.4 …
Past Year Use of Rohypnol
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
8th grade 1.0 0.8 0.8 0.5 0.5 0.7 0.3 0.5
10th grade 1.1 1.3 1.2 1.0 0.8 1.0 0.7 0.6
12th grade 1.1 1.2 1.4 1.0 0.8 0.9 1.6 1.3
College students …
Young adults …
Levels of significance of difference between the two most recent classes: *=.05, **=.01, ***=.001.
... indicates data are not availablePatterns of Club Drug Use in the U.S., 2004
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Eighty-four percent mentioned using other drugs with
GHB, including alcohol (64%), cocaine (15%), or
marijuana (14%). GHB users were far more likely than
other club drug users to report drinking alcohol at the
same time (Exhibit 9). GHB and alcohol have a syner-
gistic effect that can produce serious side effects,
including unconsciousness. Of the known motives
for using GHB, 80% reported psychic effects, and the
reason for emergency room contact was overdose
(61%) or unexpected reaction (36%) (Exhibit 10).
Ketamine
Ketamine, a derivative of phencyclidine hydrochloride,
is an anesthetic that has been approved for human and
animal use, both in trauma and emergency surgery as
well as in veterinary medicine. Ketamine on the street is
also known as Special K, Vitamin K, K, kit-kat, keets,
super acid, super k, and jet.
Ketamine users try to achieve or “fall into” a “K-Hole,”
which is described as physical immobilization and social
detachment lasting up to an hour. It is characterized
by a distorted sense of space, such as a small room
appearing the size of a football field, and an indistinct
awareness of time, such as a few minutes seeming like
an hour. The K-Hole ends rather abruptly but can be
quickly reentered following another dose of ketamine.
Ketamine is a Schedule III controlled substance and is
available in powder, tablet, and injectable forms. It is
difficult to manufacture, and most abusers acquire it
through diversion of the prescription product or
theft from veterinary supplies. Recreational users
usually administer ketamine intranasally, although it
is also injected.
Abuse of ketamine was first
reported at a CEWG meeting in
December, 1991. At the June
and December, 2003 CEWG
meetings, ketamine use was
reported as higher and demand
was greater than availability in
Detroit; use was down in Boston,
Los Angeles, Newark, and San
Francisco. In Texas, there were
eight calls in 1998 to poison
control centers about misuse
or abuse of ketamine, and there
were 12 calls in the first half of 2003. Nine clients with
problems with ketamine entered public treatment
programs in Texas in the first half of 2003.
NFLIS reported that while ketamine was a very small
proportion of all drugs analyzed, the proportion of
seizures increased through 2002 (Exhibit 2). In 1999,
there were 224 ketamine items (0.05%), as compared to
1471 in 2002 (0.16%). Ketamine comprised 9% of all
the club drugs analyzed in the first half of 2003.
The MTF survey reported past year use of ketamine
peaked in 2000 for secondary students. The decreases
between 2002 and 2003 were not statistically significant.
Use of ketamine by college students and young adults
was as low or lower than prevalence rates for secondary
students (Exhibit 3). The NSDUH survey did not ask
about ketamine.
The number of mentions of ketamine in the DAWN
emergency room system increased from 19 in 1994 to
Levels of ketamine use have historically been
low, and current data trends are mixed.
Ketamine users were older than LSD and
ecstasy users and they tended to be male.
They used multiple drugs and in addition to
marijuana, alcohol, and ecstasy, they were
likely to use “harder” drugs such as heroin
and cocaine. Ketamine was taken for its
psychic effects, and users entered hospital
emergency departments because of over-
dose or unexpected reactions.
Exhibit  4. Ecstasy/MDMA Use and Perceptions of Harm and 
Availability by 12th Graders: Monitoring the Future Survey, 
1989  -2003
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679 in 2001, but dropped to 260 in 2002. Exhibit 6
shows the rate per 100,000 population. Ketamine users
were older than LSD or ecstasy users but younger than
users of GHB or methamphetamine (Exhibit 7). In
2002, 77% of the patients were male; 67% were Anglo,
8% Hispanic, and race/ethnicity was not reported for
26% (Exhibit 8).
Eighty percent of patients mentioning ketamine in 2002
also mentioned concurrent use of other drugs: alcohol
(29%), heroin (24%), marijuana (19%), cocaine (13%),
or ecstasy (12%). Ketamine users were more likely than
any other club drug users to report concurrent use of
heroin (Exhibit 9). The primary motive for using
ketamine was psychic effects (68%), and the known
reasons for seeking help in the emergency departments
included overdose (47%) and unexpected reaction
(28%) (Exhibit 10).
LSD
LSD (lysergic acid diethylamide) is one of the major
drugs in the hallucinogen class. It was discovered in
1938 and is one of the most potent mood-changing
chemicals. It is manufactured from lysergic acid, which
is found in ergot, a fungus that grows on rye and other
grains. It is odorless, colorless, and is sold in tablet,
capsule, and liquid forms as well as on pieces of blotter
paper that have absorbed the drug.
Typically, an LSD user feels the effects of the drug 30
to 90 minutes after taking it. The physical effects
include dilated pupils, higher body temperature, in-
creased heart rate and blood pressure, sweating, loss of
appetite, sleeplessness, dry mouth, and tremors.
At the June and December, 2003 CEWG meetings,
LSD indicators were reported as declining sharply in
most CEWG areas. The drug has been mentioned less
and less in ethnographic reports in Atlanta, while in
Texas, the number of calls to Poison Control Centers
concerning abuse or misuse of LSD dropped from 82
in 2000 to nine in 2002.
NFLIS showed that while LSD is a very small propor-
tion of all drugs analyzed, the proportion of seizures
peaked in 1998 at 0.56% and then dropped to 0.03% in
2003 (Exhibit 2).
The MTF survey reported that rates of past year use of
LSD by secondary students peaked in 1996 and has
dropped since then; the decrease between 2002 and
2003 for tenth and twelfth graders was statistically
significant. Use by college students and young adults
peaked in 1995 and the decreases between 2001 and
2002 for these groups were significant (Exhibit 3).
The NSDUH survey in 2002 reported that 10.4% of
the U.S. population ages 12 and over had ever used
LSD, 0.4% had used in the past year, and 0.0% had
used in the past month. Some 1.3% of those ages 12–
17 had used LSD in the past year, as compared to 1.8%
of those 18–25 and 0.1% of those 26 and older. LSD
incidence had been remarkably steady over the years,
but rose to 958,000 new users in 2000 and then
dropped to 606,000 new users in 2001 (Exhibit 5).
The number of new users of LSD rose to the
highest level ever in 2000, before dropping
in 2001, according to the NSDUH survey. The
decrease is also seen in the MTF survey, the
NFLIS data, and DAWN mentions. LSD users
are the youngest of all the club drug users,
and they are Anglo and the most likely to
be male. They tend to use alcohol and
marijuana with their club drug, and they also
use cocaine, heroin, and ecstasy. LSD was
taken for its psychic effects or because of
dependence, and LSD users entered hospital
emergency departments because of unex-
pected reactions.
Exhibit  5. Numbers (in Thousands) of Persons Who First Used 
a Specific Club Drug During the Years 1966-2001: 2002 NSDUH
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The number of mentions of LSD in the DAWN
emergency room system decreased from 5,158 in 1994
to 891 in 2002. Exhibit 6 shows the rate per 100,000
population. LSD users were the youngest of the
patients mentioning club drugs in emergency depart-
ments (Exhibit 7). In 2002, they were the most likely
of all club drug users to be male and 75% were Anglo;
race/ethnicity was not reported for 7% (Exhibit 8).
In 1999, the proportion of males was lower (75%),
they were more likely to be Anglo (80%), and they
were even younger (38% were ages 12–17 and 40%
were ages 18–25).
Seventy-seven percent of patients mentioning LSD in
2002 also mentioned concurrent use of other drugs:
alcohol (45%), marijuana (43%), cocaine (20%), heroin
(15%) or ecstasy (14%). LSD patients were the only
other club drug users to report that more than 5% had
used heroin concurrently with their club drug (Exhibit
9). The motives for using LSD included psychic effects
(47%) and dependence (40%), and the known reasons
for seeking help in the emergency departments included
unexpected reaction (52%), overdose (22%), and
seeking detoxification (18%) (Exhibit 10).
Methamphetamine
Methamphetamine has different forms and different
names. “Speed” is often powdered and ranges in color
from white to yellow, orange, brown, or pink. It is
usually of relatively low purity. “Pills” can be pharma-
ceutical grade amphetamines such as Adderall, Ritalin,
or Phenteramine, or the pills can be methamphetamine
powder that has been pressed into tablets that are sold
as amphetamines or ecstasy. “Ice,” also known as
“shard,” “shabu,” “tweak,” “crystal,” or “crystal meth,”
is methamphetamine that has been “washed” in a
solvent such as denatured alcohol to remove impurities.
Evaporation of the solvent yields crystals that resemble
glass shards or ice shavings. It is usually smoked and has
longer-lasting physical effects and purity levels above
80%, although low quality methamphetamine may also
be marketed as Ice.
During the June and December, 2003 meetings, CEWG
members reported that in Hawaii, use of Ice was
increasing. There were more deaths due to metham-
phetamines than due to alcohol in 2002. The suicide
rate involving methamphetamine was high, and treat-
ment admissions were increasing. In San Diego,
methamphetamine use was increasing, with most of the
drug coming from Mexico. Ice was also prevalent in San
Diego. In Los Angeles, the numbers of methamphet-
amine treatment admissions and arrestees testing
positive for methamphetamine were increasing, purity
was stable, and price was increasing. In San Francisco,
emergency room mentions and treatment admissions
were increasing. Use was widespread, with increased
dealing and usage, especially among “Fast Lane” gay
and bisexual males. In Seattle, treatment admissions
were level and emergency room admissions were down
from earlier years. While the number of laboratories
seized in Washington State was down, there were still
many small “Mom and Pop” operations.
In Phoenix, Ice was a problem and the quality was high,
with most of the drug coming from “Superlabs” in
California or Mexico. The price was up due to the
demand for Ice. In Colorado, methamphetamine was
the “big story,” with indicators such as poison control
center calls, overdose deaths, and hospital discharges
increasing. It was a major problem in the rural areas.
The proportions of Hispanic treatment admissions and
admissions over age 35 were increasing and crack
cocaine users were reported to be switching to metham-
phetamine. Most new users were smoking, rather than
injecting the drug. In Texas, treatment admissions had
increased, overdose deaths were up, and seizures were
increasing. Methamphetamine and amphetamines were
greater problems in the northern half of the state, as
Unlike the other club drugs, methamphet-
amine use is one of the largest drug
problems in the U.S. Methamphetamine has
spread from the Western states eastward.
The surveys document use is holding steady,
while use of Ice is increasing. Methamphet-
amine (including Ice) is used in the urban
party scene and also in rural areas. Metham-
phetamine mentions in DAWN are increasing.
These patients are the oldest of the club
drug users, and they are the least likely to
use multiple drugs. The primary motive for
use is dependence on the drug, and an
overdose or unexpected reaction is the main
reason for an emergency room visit.Patterns of Club Drug Use in the U.S., 2004
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documented by the Texas NFLIS data.
Methamphetamine was both imported from
Mexico and also cooked in small laboratories
in the more rural areas of the state. Ice was a
growing problem in the state, with more
treatment admissions for smoking than
inhaling.
In Minneapolis and St. Paul, methamphet-
amine use was increasing, especially in the
rural areas. In Missouri, methamphetamine
was the primary illicit drug of abuse in rural
areas, and treatment admissions were in-
creasing. Use was increasing among African
American users in Kansas City.
In Michigan, laboratory seizures were
increasing, smoking was the primary
route of administration, and treatment
admissions were increasing for both
methamphetamines and prescription
amphetamines. In Chicago, use had re-
mained low but was more prevalent in the
downstate rural counties. “Tweak,” which
has a crystal-like appearance, was seen in
Chicago clubs and it was more commonly
smoked than injected.
In Atlanta, methamphetamine use was up,
with more local laboratories seized. Mexi-
can methamphetamine was also available.
Use among African Americans was increasing, as well as
use among teenagers. Among rural users, some 60%
were female and smoking was the most popular route
of administration. Ice and “Shards” were the choices.
In Miami, “Tina” was popular in the gay bathhouse
scene, and methamphetamine abuse was described an
emerging drug epidemic. In New York City, there had
been a slight increase in availability of methamphet-
amine, and some crystal meth was being sold. Recent
seizures of laboratories in rural areas in New York
indicated the continuing spread of methamphetamine
eastward. And in Boston, methamphetamine use was
emerging in the club drug scene.
Methamphetamine has been among the top three or
four drugs identified by NFLIS each year (Exhibit 1),
and the proportion has risen from 3.6% in 1997 to
11.8% in the first half of 2003 (Exhibit 2). NFLIS
shows the dominance of methamphetamine in the
West. In the Western region, 36.6% of the items were
methamphetamine, as compared to 7.8% in the Mid-
west, 6.7% in the South, and 0.2% in the Northeast. In
addition, of the drug combinations tested in the first
half of 2003, methamphetamine was present in about
18%. Cannabis, amphetamine, and cocaine were the
most common substances identified in combination
with methamphetamine. Other drugs of abuse found
in combination with methamphetamine included
ecstasy, heroin, and ketamine. Pseudoephedrine,
dimethylsulfone, and red phosphorus were found in
other samples, which reflected the impurities resulting
from clandestine manufacturing processes.
The MTF survey showed that past year use of metham-
phetamine peaked in 1999. The MTF also queried
twelfth graders, college students, and young adults
about their past year use of Ice, and use increased
through 2002, but the decrease for twelfth graders
Exhibit  6. Emergency Room Mentions of Selected Club Drugs 
per 100,000 Population for the Coterminous US: 1994-2002
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Exhibit 7. Age Groups of Patients Mentioning Club Drugs 
in DAWN Emergency Departments in the Coterminous US: 2002
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between 2002 and 2003 was statistically
significant (Exhibit 3). Among twelfth
graders, the percentage who thought it
harmful to try crystal meth or Ice once
or twice dropped from an all-time high
of 54% in 2002 to 51% in 2003, and
perceived availability of crystal meth
dropped from a high of 28% in 2001
and 2002 to 26% in 2003.
The NSDUH survey in 2002 reported that 5.3% of the
U.S. population ages 12 and over had ever used meth-
amphetamine, 0.7% had used in the past year, and 0.3%
had used in the past month. Some 0.9% of those ages
12–17 had used methamphetamine in the past year, as
compared to 1.7% of those 18–25 and 0.4% of those
26 or older. Incidence of methamphetamine use had
remained fairly level since the early 1980s but increased
to a high of 454,000 new users in 1998. Since then,
there have been no statistically significant changes.
There were an estimated 326,000 new methamphet-
amine users in 2001 (Exhibit 5).
The number of mentions of methamphetamine in the
DAWN emergency room system has varied but has
been increasing since 1999 and reached its highest level
of 17,696 mentions in 2002 (Exhibit 6). Exhibit 7
shows that methamphetamine users were the oldest of
the club drug patients. In 2002, 59% of the patients
were male; 69% were Anglo, 9% Hispanic, and 5% were
African American (Exhibit 8). In comparison, in 1999
the proportion of Anglo users was higher (74%) but
there was no difference in the age groups between 1999
or 2002.
Of the club drug users, methamphetamine patients
were the least likely to use multiple drugs (53%), as
compared to 84% of GHB users. Other drugs used
concurrently included alcohol (23%), marijuana (20%),
or cocaine (16%) (Exhibit 9). The motives for using
methamphetamine included dependence (58%) or
psychic effects (22%), and the reasons for seeking
emergency room treatment included overdose (28%),
unexpected reaction (23%), wanting detoxification
(22%), and chronic effects (17%), which demonstrates
the demand for treatment by methamphetamine users
(Exhibit 10).
Rohypnol
Rohypnol (flunitrazepam) is a benzodiazepine originally
formulated for preoperative anesthesia or sedation and
treatment of insomnia. At low doses, it acts as a muscle
relaxant and a sedative-hypnotic. At higher doses, it can
cause lack of muscle control and loss of consciousness.
Flunitrazepam has had a long history of abuse by
heroin and cocaine addicts, and because it was specifi-
cally formulated to produce anterograde amnesia, it has
been used to commit sexual assault. In addition, it has
gained popularity among youths as a “cheap drunk.”
Because flunitrazepam has never been legally marketed
in the U.S., almost all references to the drug in the U.S.
use the brand name, Rohypnol. Street names include
roofies, la rocha, roche, R2, rope, FM2, forget-me pill,
rowie, run-trip-and-fall, los dos, and Mexican valium.
Rohypnol was first reported at a CEWG meeting in
June, 1993. There were occasional mentions of the drug
in calls to the Florida Drug Hotline in the late 1980s.
The problem grew after Hurricane Andrew struck
south Florida in August 1992, which resulted in an
influx of out-of-state construction workers (“roofers
from hell”) who found cocaine in Miami, introduced
speed, and began trading drugs for drugs (hence the
Rohypnol use has dropped dramatically
since it became illegal to import it into the
U.S., yet it continues to be a problem among
Hispanic populations on the Mexico border
and in Miami. Rohypnol users are the most
likely of all club drug users to report taking
a club drug for psychic effects, and they are
the most likely to enter the emergency
departments because of unexpected
reactions to the drug.
Exhibit 8. Characteristics of Patients Mentioning Club Drugs in DAWN Emergency 
Departments in the Coterminous US: 2002
Ecstasy GHB Ketamine LSD Methamphetamine Rohypnol
% Male 50% 66% 77% 87% 59% 79%
%Anglo 64% 92% 67% 75% 69% ---
% Black 12% 1% --- 9% 5% 5%
% Hispanic 9% --- 8% 9% 9% 68%
Dashes (---) indicate that an estimate has been suppressed due to incomplete data.Patterns of Club Drug Use in the U.S., 2004
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name “roofies”). By November, 1994, it was a problem
along the Texas-Mexico border, and subsequently
spread northward and was identified in at least 32 states.
In 1996, the U.S. government prohibited the importa-
tion of the drug into the country, but it remains
available in other countries and continues to be illegally
brought into the U.S. Generic varieties of flunitraze-
pam are available in various countries. In 2001, Roche
reformulated the pill to be a grayish-green oval tablet.
In an attempt to deter sexual assault, it now contains a
dye which will turn blue in liquid. Sexual predators have
been reported to serve blue punches and fruit drinks.
At the June and December, 2003 CEWG meetings,
Rohypnol was reported down in Miami, “quiet” in St.
Louis, and a continuing problem along the Texas
border. While Texas poison control centers and Texas
NFLIS data show Rohypnol use was dropping, the
number of admissions to public treatment for a prob-
lem with Rohypnol increased from 247 in 1998 to 368
in 2002.
Only 74 items were identified in NFLIS as being
flunitrazepam in 2002, and these comprised only 0.35%
of all the benzodiazepines identified. Alprazolam
(Xanax) made up 54% of the benzodiazepine items.
The MTF survey reported that past year use of
Rohypnol by eighth graders peaked in 1996 and peaked
for tenth graders in 1997. It peaked for twelfth graders
in 2002 (Exhibit 3). In 2002, the Texas Secondary
School Survey found that students in grades 7–12 who
lived on the Texas border reported 6.7% past year use
of Rohypnol, as compared to 2.1% past year use by
Texas students not living on the border.
The NSDUH survey reported that 0.2% of the popula-
tion had ever used Rohypnol. Some 0.2% of those ages
12–17 reported lifetime use, as compared to 0.5% of
those 18–25 and 0.1% of those 26 and older.
The number of mentions in DAWN emergency depart-
ments peaked at 114 in 1996; by 2001, the numbers
were too imprecise to be considered reliable, so no rates
for Rohypnol are shown in Exhibit 6. However, analysis
of other drugs used by Rohypnol clients entering public
treatment in Texas in 2003 found that 48% also used
marijuana, 25% used cocaine, and 7% used heroin. In
2002, there were 19 mentions of Rohypnol in emer-
gency departments nationwide, and they were older
than LSD, ecstasy, and ketamine patients, but younger
than GHB and methamphetamine patients (Exhibit 7).
Seventy-nine percent were male; gender of the other
21% was not reported. Some 68% were Hispanic; race/
ethnicity was not reported for 21% (Exhibit 8).
When the motives for using the substances were
reported, Rohypnol patients were the most likely to
report they used the drug for psychic effects, and
Exhibit 9. Presence of Other Drugs in DAWN ED Visits Involving Club Drugs for the Coterminous US: 2002
#%#%#%#%#%
Drug Concomitance
Single-drug visits 1,121 28% 531 16% 52 20% 204 23% 8,404 47%
Multi-drug visits 2,905 72% 2,799 84% 208 80% 687 77% 9,292 53%
Total Club Drug Visits 4,026 3,330 260 891 17,696
Selected Drug Combinations
GHB 198 5% --- --- 9 3% 5 1% 240 1%
Ketamine 31 1% 9 0% --- --- 9 1% 18 0%
LSD 122 3% 5 0% 9 3% --- --- 42 0%
MDMA (Ecstasy) --- --- 198 6% 31 12% 122 14% 173 1%
Methamphetamine 173 4% 240 7% 18 7% 42 5% --- ---
Alcohol-in-combination 1,594 40% 2,131 64% 76 29% 402 45% 4,001 23%
Amphetamines 75 2% 184 6% 10 4% 18 2% 358 2%
Cocaine 815 20% 501 15% 34 13% 175 20% 2,816 16%
Heroin 184 5% 7 0% 63 24% 130 15% 599 3%
Marijuana 1,555 39% 458 14% 50 19% 382 43% 3,460 20%
Ecstasy (MDMA) Methamphetamine GHB Ketamine LSDPatterns of Club Drug Use in the U.S., 2004
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they were the most likely
to have come to the
emergency department
because of an unex-
pected reaction
(Exhibit 10 ).
Conclusions
Although club drugs
have attracted significant
national attention, other
than methamphetamine,
they comprise a very
small portion of the
drug abuse problem in the U.S. based on DAWN,
NFLIS, and the MTF and NSDUH surveys.
Use of methamphetamine continues to increase, while
use of LSD, Rohypnol, ketamine, GHB, and ecstasy
appears to be decreasing. While the recent decrease in
ecstasy in MTF was significant, decreases in the use of
ketamine and GHB are less pronounced and prevention
efforts should continue to focus on perceptions of risk,
peer disapproval, and availability to ensure that all these
decreases are not temporary.
Users of each of the club drugs tend to be very differ-
ent in terms of sociodemographic characteristics,
patterns of multiple drug use, and reasons for use
(psychic effects v. dependence). Prevention and
treatment efforts should be tailored to these specific
differences.
The levels of concomitant use of cocaine by users of
ecstasy, GHB, ketamine, LSD, methamphetamine, and
Rohypnol, and the levels of use of heroin by ketamine
and LSD users are of concern in terms of dependence
and treatment need.
The different reasons reported for use of each of these
drugs indicate a need to tailor treatment readiness
techniques as appropriate.
Overdose was the first or second reason given as to why
individuals sought care in the emergency department,
which shows the need for specialized protocols to treat
each of these different drugs in the acute care setting.
The mentions of suicide as a motive for using club
drugs may reflect the psychological effects of some of
these drugs. They also reflect the mental health prob-
lems of some users and the need to provide treatment
for co-occurring substance abuse and mental health
conditions.
The number of persons coming to emergency depart-
ments who are dependent on a club drug or who are
seeking detoxification is indicative of the need for
substance abuse treatment services for club drug users.
Medical and behavioral treatment protocols need to be
tailored to the pharmacological effects of each drug as
well as be culturally relevant to the different clients.
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